Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tick bite prophylaxis with doxycycline in the Netherlands
NL-OMON27133Phase 4Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doxycycline in Lyme borreliosis (2 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Prophylaxis efficacy and Number needed to treat. Started Apr 2013; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
Lyme borreliosis
Beyond the preview
Go deeper on NL-OMON27133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27133.